SPS
OLMA icon

Susquehanna Portfolio Strategies’s Olema Pharmaceuticals OLMA Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.85M Buy
147,669
+33,827
+30% +$453K 0.03% 447
2026
Q1 		$1.7M Sell
113,842
-7,500
-6% -$167K 0.03% 530
2025
Q4 		$3.03M Hold
121,342
– – 0.05% 410
2025
Q3 		$1.19M Sell
121,342
-9,000
-7% -$54K 0.02% 639
2025
Q2 		$555K Buy
130,342
+116,217
+823% +$518K 0.01% 631
2025
Q1 		$53.1K Buy
+14,125
New +$71K 0.02% 159
2024
Q3 		– Sell
-26,549
Closed -$287K – 454
2024
Q2 		$287K Sell
26,549
-8,059
-23% -$87.4K 0.01% 430
2024
Q1 		$392K Sell
34,608
-1,800
-5% -$23.2K 0.01% 626
2023
Q4 		$511K Buy
+36,408
New +$489K 0.01% 760

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Susquehanna Portfolio Strategies's OLMA Position: Q2 2026 in Review

Susquehanna Portfolio Strategies increased its Olema Pharmaceuticals (OLMA) stake by 30% in Q2 2026, buying an estimated $453K and bringing the position to 147,669 shares worth $1.85M. The position accounts for 0.03% of the portfolio, ranked #447.

Susquehanna Portfolio Strategies first reported a position in OLMA in Q4 2023 and has held it in 9 quarters since. The position peaked at $3.03M in Q4 2025. 184 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Susquehanna Portfolio Strategies held 147,669 shares of Olema Pharmaceuticals worth $1.85M as of Q2 2026.
  • Susquehanna Portfolio Strategies bought 33,827 Olema Pharmaceuticals shares in Q2 2026, an estimated $453K.
  • Olema Pharmaceuticals made up 0.03% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #447 holding.
  • Susquehanna Portfolio Strategies first reported a position in Olema Pharmaceuticals in Q4 2023 and has held it in 9 quarters since.
  • Susquehanna Portfolio Strategies's Olema Pharmaceuticals position peaked at $3.03M in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.